Long-term study supports cardiovascular safety of contemporary hormone replacement therapy

A large, long-term study of over 52,000 women in Israel found that contemporary hormone replacement therapy does not increase the risk of heart attack, stroke, blood clots, or death in women aged 45 to 59.

Originally published by gnews